Skip to main content
. 2003 Apr 22;2003(2):CD000218. doi: 10.1002/14651858.CD000218
Methods Randomisation done, description not given.
Double blind trial.
Preparations in neutral packaging.
Participants 100 women with trichomoniasis in Sweden.
Most partners were treated.
Exclusion criteria: concurrent infection with other pathogen found.
Interventions Nifuratel 200 mg by mouth 3 times a day for 7 days plus 250 mg intravaginally daily for 10 days, versus metronidazole 200 mg by mouth 3 times a day for 7 days plus 500 mg intravaginally daily for 10 days.
Outcomes Parasitological and clinical cure. Side effects.
Notes Diagnosis by smear and symptomology.
Follow up 14 days after treatment (patients found positive receive another treatment with the same regimen and are examined again after 14 days).
12% loss to follow up in nifuratel group, 3% in metronidazole group.